Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Disc Medicine (IRON)
NASDAQ:IRON
Disc Medicine (IRON) Stock Price & Analysis
198 Followers
IRON Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$25.60 - $77.60
Previous Close$31.84
Volume93.18K
Average Volume (3M)498.94K
Market Cap
$795.05M
Enterprise Value$428.86M
Total Cash (Recent Filing)$360.38M
Total Debt (Recent Filing)$2.10M
Price to Earnings (P/E)-9.4
Beta0.60
Next Earnings
Aug 09, 2024EPS Estimate
-$1.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.39
Shares Outstanding24,721,666
10 Day Avg. Volume289,158
30 Day Avg. Volume498,939
Standard Deviation0.22
R-Squared0.00836
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)2.22
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-10.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-6.65
Forecast
1Y Price Target
$57.33Price Target Upside78.26% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Disc Medicine News
Bulls Say, Bears Say
Bulls Say
Financial StabilityDisc Medicine reported a strong cash position, with sufficient funds to support operations well into 2026.
Pipeline DevelopmentIRON is well-positioned to leverage their red blood cell expertise across a balanced and unique portfolio of opportunities in the hematology space.
Product EfficacyPatients treated with 60mg bitopertin demonstrated significant reductions in phototoxic reactions and improvements in patient quality of life.
Bears Say
Clinical TrialsThe placebo group's performance exceeded expectations, which may add risk to future Phase III studies.
Drug EfficacyRecent Aurora readout continuing to weigh on shares with investors looking for clarity on the high placebo responses.
Financial PerformanceThe company reported a higher than expected loss per share and an increase in operating loss due to the advancement of its portfolio and increased headcount.
---
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IRON FAQ
What was Disc Medicine’s price range in the past 12 months?
Disc Medicine lowest stock price was $25.60 and its highest was $77.60 in the past 12 months.
What is Disc Medicine’s market cap?
Currently, no data Available
When is Disc Medicine’s upcoming earnings report date?
Disc Medicine’s upcoming earnings report date is Aug 09, 2024 which is in 86 days.
How were Disc Medicine’s earnings last quarter?
Disc Medicine released its earnings results on May 09, 2024. The company reported -$1.09 earnings per share for the quarter, missing the consensus estimate of -$1.008 by -$0.082.
Is Disc Medicine overvalued?
According to Wall Street analysts Disc Medicine’s price is currently Undervalued.
Does Disc Medicine pay dividends?
Disc Medicine does not currently pay dividends.
What is Disc Medicine’s EPS estimate?
Disc Medicine’s EPS estimate is -$1.16.
How many shares outstanding does Disc Medicine have?
Disc Medicine has 24,721,666 shares outstanding.
What happened to Disc Medicine’s price movement after its last earnings report?
Disc Medicine reported an EPS of -$1.09 in its last earnings report, missing expectations of -$1.008. Following the earnings report the stock price went up 4.874%.
Which hedge fund is a major shareholder of Disc Medicine?
Among the largest hedge funds holding Disc Medicine’s share is Perceptive Advisors LLC. It holds Disc Medicine’s shares valued at 59M.
---
Disc Medicine Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$57.33 (78.26% Upside)
$57.33 (78.26% Upside)
Blogger Sentiment
Bullish
IRON Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 161.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 12.8%
Last 30 Days ▼ 12.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-4.09%
12-Months-Change
Fundamentals
Return on Equity
-28.23%
Trailing 12-Months
Asset Growth
45.29%
Trailing 12-Months
Company Description
Disc Medicine
FS Development Corp is a blank check company.
---
IRON Stock 12 Month Forecast
Average Price Target
$57.33
▲(78.26% Upside)
Technical Analysis
Best Analysts Covering IRON
1 Year
1 Year Success Rate
2/8 ratings generated profit
1 Year Average Return
-21.52%
reiterated a buy rating 6 days ago
Copying Benjamin Burnett's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -21.52% per trade.
---